C
Celldex Therapeutics, Inc. (CLDX)
NCM – Real vaqt narxi. Valyuta: USD
32.00
-0.28 (-0.87%)
Yopilishda: May 12, 2026, 4:00 PM EDT
32.20
+0.20 (0.63%)
Bozor oldidan: May 13, 2026, 7:41 AM EDT
Find any stock by ticker or company name

NCM – Real vaqt narxi. Valyuta: USD
32.00
-0.28 (-0.87%)
Yopilishda: May 12, 2026, 4:00 PM EDT
32.20
+0.20 (0.63%)
Bozor oldidan: May 13, 2026, 7:41 AM EDT
This stock has a consensus price target of $52.17 based on the ratings of 14 analysts. The high is $90.00 and the low is $34.00.
| Maqsad | Min. maqsadli narx | O‘rtacha maqsadli narx | Maks. maqsadli narx |
|---|---|---|---|
| Narx | $ 34 | $ 52.17 | $ 90 |
| O’zgarish | 6.25% | 63.03% | 181.25% |
| Sana | O‘sish/pasayish potensiali | Tahlilchi firmasi | Maqsadli narx | Reyting o‘zgarishi | Reyting |
|---|---|---|---|---|---|
| 2026-05-08 | 49.07% | Barclays | $45 → $48 | Maintains | Overweight |
| 2026-04-20 | 39.75% | Barclays | $24 → $45 | Upgrades | Underweight → Overweight |
| 2026-03-02 | 5.59% | Goldman Sachs | $30 → $34 | Maintains | Neutral |
| 2026-02-26 | 111.18% | Stifel | $58 → $68 | Reiterates | Buy |
| 2025-12-17 | -25.47% | Barclays | $21 → $24 | Maintains | Underweight |